Rick Wise
Stock Analyst at Stifel Nicolaus
(1.33)
# 3,661
Out of 5,051 analysts
804
Total ratings
49%
Success rate
-0.3%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterated: Hold | $260 | $263.73 | -1.41% | 32 | Oct 12, 2026 | |
| SYK Stryker | Reiterated: Buy | $360 → $330 | $282.60 | +16.77% | 35 | Sep 30, 2026 | |
| SOLV Solventum | Reiterated: Buy | $100 | $85.31 | +17.22% | 13 | Sep 18, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $50 → $65 | $57.28 | +13.48% | 36 | Sep 17, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $30 | $26.91 | +11.48% | 9 | Sep 15, 2026 | |
| MDT Medtronic | Reiterated: Hold | $80 → $95 | $91.93 | +3.34% | 51 | Sep 2, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $40 → $45 | $50.56 | -11.00% | 7 | Aug 14, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $195 | $188.89 | +3.23% | 33 | Aug 11, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $3 → $4.5 | $4.10 | +9.76% | 25 | Aug 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $21.79 | +106.52% | 21 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $4.01 | +49.63% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.21 | $9.83 | +44.56% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $45 | $35.76 | +25.84% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $105 → $110 | $92.17 | +19.34% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $24 | $22.08 | +8.70% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $85 | $77.27 | +10.00% | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $82.91 | +44.74% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $28 | $24.78 | +12.99% | 37 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $67.74 | +18.10% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $1.80 | +38.89% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $60 | $43.84 | +36.86% | 67 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $86.39 | +27.33% | 51 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $670 → $550 | $427.64 | +28.61% | 49 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $101.82 | +17.86% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 | $45.36 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.000001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.01 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $34 | $16.45 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $523.94 | n/a | 2 | Nov 8, 2012 |
Johnson & Johnson
Oct 12, 2026
Reiterated: Hold
Price Target: $260
Current: $263.73
Upside: -1.41%
Stryker
Sep 30, 2026
Reiterated: Buy
Price Target: $360 → $330
Current: $282.60
Upside: +16.77%
Solventum
Sep 18, 2026
Reiterated: Buy
Price Target: $100
Current: $85.31
Upside: +17.22%
AtriCure
Sep 17, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $57.28
Upside: +13.48%
Kestra Medical Technologies
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $26.91
Upside: +11.48%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $80 → $95
Current: $91.93
Upside: +3.34%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $40 → $45
Current: $50.56
Upside: -11.00%
Becton, Dickinson and Company
Aug 11, 2026
Reiterated: Buy
Price Target: $195
Current: $188.89
Upside: +3.23%
Treace Medical Concepts
Aug 11, 2026
Reiterated: Hold
Price Target: $3 → $4.5
Current: $4.10
Upside: +9.76%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $21.79
Upside: +106.52%
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $4.01
Upside: +49.63%
Aug 7, 2026
Reiterated: Buy
Price Target: $14.21
Current: $9.83
Upside: +44.56%
Aug 6, 2026
Rated: Buy
Price Target: $50 → $45
Current: $35.76
Upside: +25.84%
Aug 6, 2026
Rated: Buy
Price Target: $105 → $110
Current: $92.17
Upside: +19.34%
Aug 5, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $22.08
Upside: +8.70%
Aug 5, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $77.27
Upside: +10.00%
Aug 5, 2026
Reiterated: Buy
Price Target: $120
Current: $82.91
Upside: +44.74%
Jul 31, 2026
Reiterated: Hold
Price Target: $19 → $28
Current: $24.78
Upside: +12.99%
Jul 30, 2026
Reiterated: Buy
Price Target: $80
Current: $67.74
Upside: +18.10%
Jul 30, 2026
Reiterated: Buy
Price Target: $2.5
Current: $1.80
Upside: +38.89%
Jul 29, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $43.84
Upside: +36.86%
Jul 24, 2026
Reiterated: Buy
Price Target: $110
Current: $86.39
Upside: +27.33%
Jul 17, 2026
Rated: Buy
Price Target: $670 → $550
Current: $427.64
Upside: +28.61%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $101.82
Upside: +17.86%
May 1, 2025
Reiterated: Hold
Price Target: $55
Current: $45.36
Upside: n/a
Jun 3, 2023
Reiterated: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $2.01
Upside: n/a
Aug 22, 2018
Reiterated: Hold
Price Target: $25 → $34
Current: $16.45
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $523.94
Upside: n/a